P. J. van den Elsen

发表

CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis

R. Ravid, E. S. van Haastert, K. Biber, 2003, Journal of neuropathology and experimental neurology.

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

H. Putter, P. Kuppen, C. V. D. van de Velde, 2010, The Journal of Immunology.

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes

C. Laurent, Sake I. van Pelt, G. Luyten, 2016, PloS one.

Regulation of MHC class I and II gene transcription: differences and similarities

P. J. van den Elsen, A. Peijnenburg, S. J. P. Gobin, 1998, Immunogenetics.

NLRC5 Cooperates with the RFX Transcription Factor Complex To Induce MHC Class I Gene Expression

Amy Li, Kyoung-Hee Lee, A. Biswas, 2012, The Journal of Immunology.

Non-random employment of V beta 6 and J beta gene elements and conserved amino acid usage profiles in CDR3 regions of human fetal and adult TCR beta chain rearrangements.

P. J. van den Elsen, E. Kaijzel, M. V. van Tol, 1994, International immunology.

Cloning of the MCF1233 murine leukemia virus and identification of sequences involved in viral tropism, oncogenicity and T cell epitope formation.

C. Melief, W. Loenen, P. J. van den Elsen, 1994, Virus research.

Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation.

I. Tezcan, P. J. van den Elsen, A. Peijnenburg, 1999, Blood.

Characterization of tumor antigens in cells transformed by fragments of adenovirus type 5 DNA.

A. van der Eb, P. Schrier, P. J. van den Elsen, 1979, Virology.

Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

A. Houweling, A. van der Eb, P. J. van den Elsen, 1980, Virology.

The relationship between region E1a and E1b of human adenoviruses in cell transformation.

A. Houweling, A. van der Eb, P. J. van den Elsen, 1982, Gene.

Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.

M. Jager, P. J. van den Elsen, L. V. van Dinten, 2005, Investigative ophthalmology & visual science.

The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development

J. Jukema, P. Quax, C. Gongora, 2017, PloS one.

T Cell Factor 1 Represses CD8+ Effector T Cell Formation and Function

F. Staal, P. J. van den Elsen, R. Arens, 2014, The Journal of Immunology.

Differential Expression Regulation of the α and β Subunits of the PA28 Proteasome Activator in Mature Dendritic Cells1

P. Kloetzel, P. Ricciardi-Castagnoli, F. Granucci, 2005, The Journal of Immunology.

HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases.

P. Kuppen, C. V. D. van de Velde, H. Gelderblom, 2016, Human immunology.

NOVEL HUMAN MHC CLASS I GENES ARE EXPRESSED BY TUMOUR CELL LINES REPRESENTING EMBRYONIC AND EXTRAEMBRYONIC TISSUES

T. F. Rinke de Wit, P. Stern, J. Glazebrook, 1989, Journal of immunogenetics.

Epigenetics in atherosclerosis and inflammation

J. Jukema, P. Quax, Rutger J. Wierda, 2010, Journal of cellular and molecular medicine.

The MHC class II deficiency syndrome: heterogeneity at the level of the response to 5-azadeoxycytidine.

P. J. van den Elsen, R. Schuurman, M. Kraakman, 1990, Research in immunology.

Identification of adenovirus-type 12 gene products involved in transformation and oncogenesis.

A. van der Eb, P. Schrier, H. Jochemsen, 1982, Virology.

Analysis of the peripheral T-cell compartment in the MHC class II deficiency syndrome.

F. Mascart, M. Andrien, E. Dupont, 1991, Research in immunology.

Regulation of human beta 2-microglobulin transactivation in hematopoietic cells.

P. J. van den Elsen, P. Biesta, S. Gobin, 2003, Blood.

Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins.

P. J. van den Elsen, L. Struyk, G. Hawes, 1993, Journal of immunology.

T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome.

P. J. van den Elsen, M. V. van Tol, J. Vossen, 2000, Human immunology.

Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance

Koichi S. Kobayashi, P. J. van den Elsen, T. Sidiq, 2019, Immunogenetics.

Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.

P. J. van den Elsen, N. van der Stoep, Edwin Quinten, 2007, Molecular immunology.

Genetic and Epigenetic Control of the Major Histocompatibility Complex Class Ib Gene HLA‐G in Trophoblast Cell Lines

Rutger J. Wierda, P. J. van den Elsen, M. van Eggermond, 2009, Annals of the New York Academy of Sciences.

HLA-G Transactivation by cAMP-response Element-binding Protein (CREB)

P. J. van den Elsen, J. D. de Steenwinkel, P. Biesta, 2002, The Journal of Biological Chemistry.

Rearrangement and expression of T-cell receptor delta genes in T-cell acute lymphoblastic leukemias.

J. V. van Dongen, P. J. van den Elsen, J. Borst, 1989, Blood.

A novel T-cell-defined HLA-DR polymorphism not predicted from the linear amino acid sequence.

F. Koning, P. J. van den Elsen, A. Termijtelen, 1989, Human immunology.

Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.

J. Jukema, P. Quax, B. Heijmans, 2008, European heart journal.

Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Anita H. Undale, E. Celis, P. J. van den Elsen, 2004, International immunology.

A Novel Autocrine Pathway of Tumor Escape from Immune Recognition: Melanoma Cell Lines Produce a Soluble Protein That Diminishes Expression of the Gene Encoding the Melanocyte Lineage Melan-A/MART-1 Antigen Through Down-Modulation of Its Promoter

I. S. Dunn, P. J. van den Elsen, E. Benson, 2001, The Journal of Immunology.

Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines

M. Griffioen, I. Ouwerkerk, P. Schrier, 1999, Immunogenetics.

Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.

J. Neefjes, T. Groothuis, H. Kuipers, 2005, Human immunology.

Melanoma antigen recognition by tumour‐infiltrating T lymphocytes (TIL): effect of differential expression of Melan‐A/MART‐1

S. Pervaiz, P. J. van den Elsen, L. Boyle, 2000, Clinical and experimental immunology.

Affinity, specificity and T‐cell‐receptor diversity of melanoma‐specific CTL generated in vitro against a single tyrosinase epitope

S. H. van der Burg, C. Melief, C. Melief, 1997, International journal of cancer.

In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites.

P. J. van den Elsen, L. Boyle, J. Kurnick, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Structure and function of the transforming genes of human adenoviruses and SV40.

A. van der Eb, P. Schrier, H. Jochemsen, 1980, Cold Spring Harbor symposia on quantitative biology.

Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4+ CD45RO+ T lymphocytes on the basis of CDR3 diversity.

F. Breedveld, P. J. van den Elsen, R. Dolhain, 1994, International immunology.

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients

P. Kuppen, J. Dekker, P. J. van den Elsen, 2013, British Journal of Cancer.

Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G.

P. J. van den Elsen, S. Gobin, 2000, Human immunology.

Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines.

T. F. Rinke de Wit, P. Stern, T. R. D. Wit, 1990, Journal of immunology.

T cell development in a major histocompatibility complex class II‐deficient patient

W. Kuis, P. J. van den Elsen, B. Zegers, 1993, European journal of immunology.

Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.

J. Geurts, S. Amor, P. J. van den Elsen, 2011, CNS & neurological disorders drug targets.

Antigen processing and presentation by human trophoblast-derived cell lines.

L. Wilson, P. J. van den Elsen, V. Keijsers, 1997, Journal of immunology.

Binding of labeled initiation factor IF-1 to ribosomal particles and the relationship to the mode of IF-1 action in ribosome dissociation.

L. Bosch, H. O. Voorma, P. J. van den Elsen, 1978, European journal of biochemistry.

The T cell receptor/T3 complex.

H. Spits, D. Gold, P. J. van den Elsen, 1986, The Year in immunology.

Uveal melanoma: no expression of HLA-G.

L. Wilson, P. J. van den Elsen, H. Hurks, 2001, Investigative ophthalmology & visual science.

Reduced human leukocyte antigen expression in advanced‐stage Ewing sarcoma: implications for immune recognition

U. Dirksen, M. Schilham, K. Schaefer, 2009, The Journal of pathology.

T-cell receptor beta-chain gene usage in the T-cell recognition of Mycobacterium leprae antigens in one tuberculoid leprosy patient.

J. Haanen, J. Ko, P. J. van den Elsen, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Detection and characterization of HLA class I molecules in the supernatant of an hepatocarcinoma cell line and of EBV-transformed B cell lines.

F. Claas, P. J. van den Elsen, A. Mulder, 1999, Human immunology.

Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines.

M. Greaves, M. Greaves, S. Mizutani, 1986, Blood.

Cellular immune recognition of HLA-A*0201 following gene transfer into a human embryonal carcinoma cell line.

L. Wilson, P. J. van den Elsen, T. Spies, 1994, Human immunology.

Conserved TcR β chain usage for a single MHC class II-restricted heat shock protein peptide

P. J. van den Elsen, L. Struyk, G. Hawes, 1998, Immunogenetics.

Evidence for selective usage of amino acids within CDR3 regions of T cell receptor V genes derived from synovial tissue-infiltrating CD4+CD45RO+ T-lymphocytes.

F. Breedveld, P. J. van den Elsen, R. Dolhain, 1995, Scandinavian journal of rheumatology. Supplement.

Modulation of the T cell compartment by blood transfusion. Effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor Vbeta usage.

F. Claas, P. J. van den Elsen, A. Brand, 1997, Transplantation.

Pre‐term Birth and Severe Pre‐eclampsia are not Associated with Altered Expression of HLA on Human Trophoblasts *

P. J. van den Elsen, H. Kanhai, C. V. van Meir, 2003, American journal of reproductive immunology.

Th1-like cytokine production profile and individual specific alterations in TCRBV-gene usage of T cells from newly diagnosed type 1 diabetes patients after stimulation with beta-cell antigens.

S. Martin, J. Hutton, B. Roep, 1997, Journal of autoimmunity.

Murine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genes.

C. Biron, P. J. van den Elsen, C. Terhorst, 1987, Journal of immunology.

Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA.

P. V. van Veelen, P. J. van den Elsen, F. Ossendorp, 2022, Cell reports.

Locus-specific regulation of HLA-A and HLA-B expression is not determined by nucleotide variation in the X2 box promoter element.

P. J. van den Elsen, S. Gobin, 2001, Blood.

The common regulatory pathway of MHC class I and class II transactivation.

P. J. van den Elsen, S. Gobin, 1999, Microbes and infection.

Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation.

A. Houweling, A. van der Eb, P. J. van den Elsen, 1983, Virology.

Unravelling the T‐cell‐mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34–56 peptide in incomplete adjuvant

J. Drijfhout, J. Laman, P. J. van den Elsen, 2012, European journal of immunology.

Interindividual conservation of T-cell receptor beta chain variable regions by minor histocompatibility antigen-specific HLA-A*0201-restricted cytotoxic T-cell clones.

P. J. van den Elsen, E. Goulmy, J. Pool, 1995, Blood.

The gene encoding the epsilon subunit of the T3/T-cell receptor complex maps to chromosome 11 in humans and to chromosome 9 in mice.

J. V. van Dongen, C. Morton, G. Bruns, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Exon/intron organization of the genes coding for the delta chains of the human and murine T-cell receptor/T3 complex.

P. J. van den Elsen, K. Georgopoulos, C. Terhorst, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Lymphokine gene transcription in CD4+CD8- T cells of a type III bare lymphocyte syndrome patient.

P. J. van den Elsen, M. Lambert, M. van Eggermond, 1993, Human immunology.

Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance

Koichi S. Kobayashi, P. J. van den Elsen, T. Sidiq, 2019, Immunogenetics.

Type III bare lymphocyte syndrome associated with a novel RFXAP mutation: a case report

İ. Reisli, P. J. van den Elsen, H. Artaç, 2012, International journal of immunogenetics.

Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene

P. J. van den Elsen, A. Peijnenburg, Ö. Sanal, 2000, Immunogenetics.

Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency

S. Antonarakis, W. Reith, B. Mach, 1997, Human mutation.

Human T cell repertoire generation in the absence of MHC class II expression results in a circulating CD4+CD8- population with altered physicochemical properties of complementarity-determining region 3.

O. Sanal, F. Ersoy, P. J. van den Elsen, 1996, Journal of immunology.

Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation

J. Geurts, H. D. de Vries, S. Amor, 2012, Journal of Neuroinflammation.

Selective usage of defined TCRBV genes in response to filarial antigens.

R. Maizels, E. Sartono, M. Yazdanbakhsh, 1997, International immunology.

Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.

P. J. van den Elsen, E. Schooten, Tjadine M Holling, 2004, Human immunology.

The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B.

P. J. van den Elsen, V. Keijsers, S. Gobin, 1998, Journal of immunology.

Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines

P. Kuppen, C. V. D. van de Velde, D. Hoon, 2014, Apoptosis.

Monoclonal antibodies to human embryonal carcinoma cells: antigenic relationships of germ cell tumors.

T. F. Rinke de Wit, P. Stern, M. Pera, 1991, Laboratory investigation; a journal of technical methods and pathology.

Activated Human T Cells Accomplish MHC Class II Expression Through T Cell-Specific Occupation of Class II Transactivator Promoter III1

P. J. van den Elsen, N. van der Stoep, Nienke van der Stoep, 2002, The Journal of Immunology.

Morphological transformation of human adenoviruses is determined to a large extent by gene products of region E1a.

A. Houweling, A. van der Eb, P. J. van den Elsen, 1983, Virology.

Regulation of MHC class II expression in human T-cell malignancies.

A. Langerak, P. J. van den Elsen, E. Schooten, 2004, Blood.

Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element.

A. Woltman, P. J. van den Elsen, S. Gobin, 1999, Journal of immunology.

Transcriptional regulation of antigen presentation.

H. Kuipers, P. J. van den Elsen, N. van der Stoep, 2004, Current opinion in immunology.

T cell receptor usage by HLA-DR3-specific T cell clones isolated from a renal allograft.

P. J. van den Elsen, L. Boyle, J. Kurnick, 1997, Transplant immunology.

The epigenetics of multiple sclerosis and other related disorders.

S. Amor, P. J. van den Elsen, P. Van Der Valk, 2014, Multiple sclerosis and related disorders.

Analysis of virus-specific mRNAs present in cells transformed with restriction fragments of adenovirus type 5 DNA.

A. van der Eb, P. J. van den Elsen, H. van Ormondt, 1983, The Journal of general virology.

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?

C. Teunissen, A. van Dam, P. J. van den Elsen, 2017, Journal of Neuroinflammation.

Genetic and Epigenetic Regulation of CCR5 Transcription

Rutger J. Wierda, P. J. van den Elsen, R. J. Wierda, 2012, Biology.

Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors

J. Jukema, P. Quax, J. Jukema, 2012, Journal of cellular and molecular medicine.

Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions

P. J. van den Elsen, C. D. DE GROOT, P. Van Der Valk, 2001, Glia.

Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.

E. V. van Zwet, J. Lindeman, Rutger J. Wierda, 2015, Life sciences.

A role for KMT1c in monocyte to dendritic cell differentiation: Epigenetic regulation of monocyte differentiation.

E. V. van Zwet, Rutger J. Wierda, P. J. van den Elsen, 2015, Human immunology.

Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

T. Mak, Y. Yoshikai, Y. Yanagi, 1984, Nature.

Cellular immune recognition of HLA‐G‐expressing choriocarcinoma cell line JEG‐3

P. Stern, D. Burt, P. J. van den Elsen, 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Direct assessment of junctional diversity in rearranged T cell receptor beta chain encoding genes by combined heteroduplex and single strand conformation polymorphism (SSCP) analysis.

F. Breedveld, B. de Geus, P. J. van den Elsen, 1996, Journal of immunological methods.

NLR family member NLRC5 is a transcriptional regulator of MHC class I genes

D. Iliopoulos, Amy Li, Kyoung-Hee Lee, 2010, Proceedings of the National Academy of Sciences.

Chemical and genetic control of IFNγ‐induced MHCII expression

J. Neefjes, R. Hintzen, P. J. van den Elsen, 2018, EMBO reports.

Non-random expression of T cell receptor gamma and delta variable gene segments in functional T lymphocyte clones from human peripheral blood.

J. V. van Dongen, J. Borst, E. de Vries, 1989, European journal of immunology.

Expression Regulation of Major Histocompatibility Complex Class I and Class II Encoding Genes

P. J. van den Elsen, 2011, Frontiers in immunology.

Cooperative effects of initiation factors and fMet-tRNA in the formation of the 40-S initiation complex.

J. Foekens, H. O. Voorma, P. J. van den Elsen, 1976, European journal of biochemistry.

Long-term T cell immune reconstitution in 2 SCID patients after BMT.

P. J. van den Elsen, M. V. van Tol, J. Vossen, 1998, Human immunology.

T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.

P. J. van den Elsen, M. V. van Tol, J. Vossen, 1999, Blood.

Simvastatin reduces CCL2 expression in monocyte-derived cells by induction of a repressive CCL2 chromatin state.

P. J. van den Elsen, D. Zanette, G. Haasnoot, 2014, Human immunology.

Transcriptional control of MHC genes and T cell development in MHC class II deficiency.

P. J. van den Elsen, B. Godthelp, M. van Eggermond, 1999, Archivum immunologiae et therapiae experimentalis.

Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.

W. Reith, B. Mach, J. Villard, 1997, The New England journal of medicine.

Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.

C. Wijmenga, G. Gimelli, M. van der Burg, 2011, American journal of human genetics.

Epigenetic control in immune function.

Rutger J. Wierda, P. J. van den Elsen, M. van Eggermond, 2011, Advances in experimental medicine and biology.

DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.

P. J. van den Elsen, N. van der Stoep, J. Boss, 2003, Clinical immunology.

Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not?

P. J. van den Elsen, N. van der Stoep, 2003, The American journal of pathology.

Lack of ifn‐γ‐mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines

P. J. van den Elsen, N. van der Stoep, Edwin Quinten, 2002 .

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.

P. J. van den Elsen, A. Peijnenburg, M. Eggermond, 1998, Immunity.

Assignment of the gene coding for the T3-delta subunit of the T3-T-cell receptor complex to the long arm of human chromosome 11 and to mouse chromosome 9.

D. Gerhard, D. Housman, G. Bruns, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Loss of interferon‐γ inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post‐transcriptional as well as epigenetic regulation

B. Seliger, T. Whiteside, P. J. van den Elsen, 2008, The British journal of dermatology.

Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapy.

P. J. van den Elsen, A. Brand, J. Bolk, 1997, The Journal of pediatrics.

Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter.

T. Huizinga, P. J. van den Elsen, C. Verweij, 2001, Cytokine.

Epigenetic silencing of MHC2TA transcription in cancer.

M. Jager, P. J. van den Elsen, M. van Eggermond, 2006, Biochemical pharmacology.

Epigenetic control of CIITA expression in leukemic T cells.

P. J. van den Elsen, N. van der Stoep, T. Holling, 2004, Biochemical pharmacology.

The MHC-Specific Enhanceosome and Its Role in MHC Class I and β2-Microglobulin Gene Transactivation1

S. Westerheide, P. J. van den Elsen, J. Boss, 2001, The Journal of Immunology.

Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene

P. J. van den Elsen, A. Peijnenburg, Ö. Sanal, 1999, Immunogenetics.

Intrauterine transfusions affect fetal T-cell immunity.

P. J. van den Elsen, A. Brand, H. Kanhai, 1997, Blood.

T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis.

F. Breedveld, L. Steinman, J. Oksenberg, 1993, Human immunology.

TCR V α- and V ß-Gene Segment Use in T-Cell Subcultures Derived from a Type-III Bare Lymphocyte Syndrome Patient Deficient in MHC Class-II Expression

F. Mascart, E. Dupont, P. J. van den Elsen, 1992, Developmental immunology.

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA.

P. J. van den Elsen, A. Peijnenburg, V. Keijsers, 1997, Immunity.

E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).

P. J. van den Elsen, N. van der Stoep, M. Marcondes Rezende, 2004, Blood.

The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.

I. Doxiadis, F. Claas, M. Heemskerk, 2005, Human immunology.

Shared regulatory elements in the promoters of MHC class I and class II genes.

P. J. van den Elsen, A. Peijnenburg, M. van Eggermond, 1998, Immunology today.

Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature.

J. Goeman, M. DeRuiter, A. G. Gittenberger-de Groot, 2010, The American journal of pathology.

Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

J. Harbour, M. Dogrusöz, P. A. van der Velden, 2015, Investigative ophthalmology & visual science.

Oxidative Phosphorylation Induces De Novo Expression of the MHC Class I in Tumor Cells through the ERK5 Pathway

R. Hipskind, M. Sánchez-Beato, J. Enríquez, 2010, The Journal of Immunology.

Epigenetic regulation of CIITA expression in human T-cells.

Rutger J. Wierda, V. Marquez, P. J. van den Elsen, 2011, Biochemical pharmacology.

T cell receptors in rheumatoid arthritis.

F. Breedveld, P. J. van den Elsen, J. Kurnick, 1995, Arthritis and rheumatism.

Skewing of TCR V genes to CD4+ and CD8+ subsets of T lymphocytes is not determined by amino acid composition of CDR3.

P. J. van den Elsen, H. Kanhai, G. Hawes, 1997, International immunology.

Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patient.

F. Claas, W. Weimar, P. J. van den Elsen, 1994, Transplantation.

Novel Mutations Within the RFX-B Gene and Partial Rescue of MHC and Related Genes Through Exogenous Class II Transactivator in RFX-B-Deficient Cells1

P. J. van den Elsen, A. Peijnenburg, J. Boss, 2000, The Journal of Immunology.

Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.

P. J. van den Elsen, A. Sijts, F. Ossendorp, 1994, Journal of immunology.

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients

S. Swann, J. Dekker, R. Amado, 2014, British Journal of Cancer.

Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.

L. Wilson, P. J. van den Elsen, N. van der Stoep, 2000, Human immunology.

Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.

P. J. van den Elsen, A. Peijnenburg, J. Vossen, 1999, Journal of immunology.

Transcriptional silencing of RFXAP in MHC class II-deficiency.

I. Tezcan, P. J. van den Elsen, M. van Eggermond, 2008, Molecular immunology.

Transcriptional control of MHC genes in fetal trophoblast cells.

P. J. van den Elsen, N. van der Stoep, S. Gobin, 2001, Journal of reproductive immunology.

Transcriptional regulation of HLA-G.

P. J. van den Elsen, V. Keijsers, S. Gobin, 1999, Transplantation proceedings.

Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.

H. Kuipers, P. J. van den Elsen, Hedwich F. Kuipers, 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Simvastatin affects cell motility and actin cytoskeleton distribution of microglia

H. Boddeke, E. S. van Haastert, A. Rappert, 2006, Glia.

A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma1

P. Snijders, L. Wilson, M. Jager, 2007, The Journal of Immunology.

HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic.

Arnoud Boot, P. Kuppen, C. V. D. van de Velde, 2018, Clinical immunology.

CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor.

E. S. van Haastert, H. Kuipers, P. J. van den Elsen, 2008, Blood.

Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies

A. Zwinderman, N. Sattar, R. D. de Winter, 2010, Heart.

Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer.

Arnoud Boot, P. Kuppen, C. V. D. van de Velde, 2016, Human immunology.

The regulation of HLA class I expression: is HLA-G the odd one out?

P. J. van den Elsen, S. Gobin, 1999, Seminars in Cancer Biology.

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?

C. Teunissen, A. van Dam, P. J. van den Elsen, 2017, Journal of Neuroinflammation.

Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.

P. J. van den Elsen, N. van der Stoep, Edwin Quinten, 2002, International journal of cancer.

Clonal dominance and selection for similar complementarity determining region 3 motifs among T lymphocytes responding to the HLA-DR3-associated Mycobacterium leprae heat shock protein 65-kd peptide 3-13.

J. Haanen, P. J. van den Elsen, R. de Vries, 1995, Human immunology.

T-cell repertoire development in MHC class II deficient humans.

F. Mascart, E. Dupont, P. J. van den Elsen, 1993, Advances in experimental medicine and biology.

Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells.

G. Klein, F. Koning, P. J. van den Elsen, 1994, European journal of immunology.

A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.

P. Snijders, L. Wilson, M. Jager, 2007, Journal of Immunology.

Analysis of MHC class II transcription in two type III bare lymphocyte syndrome patients of a single family.

J. V. van Ree, P. J. van den Elsen, C. Verheij, 1993, Immunodeficiency.

E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).

P. J. van den Elsen, N. van der Stoep, M. Marcondes Rezende, 2004, Blood.

Using an Extracurricular Honors Program to Engage Future Physicians Into Scientific Research in Early Stages of Medical Training

F. Dekker, P. J. van den Elsen, C. Jost, 2018, Medical Science Educator.

Molecular analysis of the T‐cell receptor β‐chain repertoire in early rheumatoid arthritis: heterogeneous TCRBV gene usage with shared amino acid profiles in CDR3 regions of T lymphocytes in multiple synovial tissue needle biopsies from the same joint

F. Breedveld, P. Tak, P. J. van den Elsen, 1996, European journal of clinical investigation.

Definition of a human suppressor T-cell epitope.

T. Ottenhoff, P. J. van den Elsen, T. Mutis, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Phenotypical heterogeneity among human T cell receptor gamma/delta-expressing clones derived from peripheral blood.

F. Koning, P. J. van den Elsen, F. Wassenaar, 1989, European Journal of Immunology.

Statins amplify TLR‐induced responses in microglia via inhibition of cholesterol biosynthesis

H. Kuipers, P. J. van den Elsen, J. Bajramovic, 2012, Glia.

Oxidative Phosphorylation Induces De Novo Expression of the MHC Class I in Tumor Cells through the ERK5 Pathway

R. Hipskind, M. Sánchez-Beato, J. Enríquez, 2010, The Journal of Immunology.

Regulation of Mhc Class Ii Expression in Human T-cell Malignancies

P. J. van den Elsen, E. Schooten, T. Holling, 2003 .